The 23 references in paper A. Shutov M., А. Шутов М. (2008) “НЕФРОПРОТЕКЦИЯ У БОЛЬНЫХ ХРОНИЧЕСКОЙ БОЛЕЗНЬЮ ПОЧЕК С ХРОНИЧЕСКОЙ СЕРДЕЧНОЙ НЕДОСТАТОЧНОСТЬЮ. МОНОТЕРАПИЯ ИНГИБИТОРАМИ АПФ ИЛИ АНТАГОНИСТАМИ РЕЦЕПТОРОВ АНГИОТЕНЗИНА II ИЛИ КОМБИНИРОВАННАЯ ТЕРАПИЯ? // NEPHROPROTECTION IN PATIENTS WITH CHRONIC KIDNEY DISEASE WITH CHRONIC CARDIAC INSUFFICIENCY. ACEI MONOTHERAPY WITH ARB OR COMBINATIONAL THERAPY” / spz:neicon:nefr:y:2008:i:4:p:93-95

1
Wolf G, Ritz E. Combination therapy with ACE inhibitors and angiotensin II receptor blockers to halt progression of chronic renal disease: pathophysiology and indications. Kidney Int 2005;67(3):799-812
(check this in PDF content)
2
Brenner BM. Retarding the progression of renal disease. Kidney Int 2003;64(1):370-378
(check this in PDF content)
3
Смирнов АВ, Каюков ИГ, Добронравов ВА. Концеп­ ция факторов риска в нефрологии: вопросы профилактики и лечения хронической болезни почек. Нефрология 2008;12(1):7-13
(check this in PDF content)
4
Doulton TWR, He FJ, MacGregor GA. Systematic review of combined angiotensin-converting enzyme inhibition and angiotenzine receptor blockade in hypertension. Hypertension 2005;45:880-886
(check this in PDF content)
5
MacKinnon M, Shurraw S, Akbari A et al. Combination therapy with an angiotensin receptor blocker and an ace inhibitor in proteinuric renal disease. A systematic review of the efficacy and safety data. Am J Kidney Dis 2006;48:8-20
(check this in PDF content)
6
Lisowska A, Musial WJ. Heart failure in patients with chronic kidney disease. Rocz Akad Med Bialymst 2004;49:162- 165
(check this in PDF content)
7
Шутов АМ, Тармонова ЛЮ. Нарушение функции почек и анемия у больных пожилого возраста с диастолической сердечной недостаточностью. Тер архив 2007;79(12):47-51
(check this in PDF content)
8
McClellan WM, Langston RD, Presley R. Medicare patients with cardiovascular disease have a high prevalence of chronic kidney disease and a high rate of progression to end- stage renal disease. J Am Soc Nephrol 2004;15:1912-1919
(check this in PDF content)
9
Herzog CA, Muster HA, Li S, Collins AJ. Impact of congestive heart failure, chronic kidney disease, and anemia on survival in the Medicare population. J Card Fail 2004 Dec;10(6):467-742
(check this in PDF content)
10
Национальные Рекомендации ВНОК и ОССН по ди­ агностике и лечению ХСН (второй пересмотр). Сердечная недостаточность 2007;39(1):4-41
(check this in PDF content)
11
Brosius FC, Hostetter TH, Kelepouris E et al. Detection of chronic kidney disease in patients with or at increased risk of cardiovascular disease. Circulation 2006;114:1083-1087
(check this in PDF content)
12
Berger AK, Duval S, Manske C et al. Angiotensin­ converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure and chronic kidney disease. Am Heart J 2007 Jun;153(6):1064-1073
(check this in PDF content)
13
Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology Eur Heart J 2005;26(11):1115- 1140
(check this in PDF content)
14
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult. J Am Coll Cardiol 2005;46(6):1-82
(check this in PDF content)
15
Executive summary: HFSA 2006 Comprehensive heart failure practice guidelines. Journal of Cardiac Failure 2006;12(1):10-38
(check this in PDF content)
16
Arnold JMO, Liu P, Demers C et al. Canadian Cardiovascular society consensus conference recommendations on heart failure 2006: Diagnosis and management. Can J Cardiol 2006;22(1):23-45.
(check this in PDF content)
17
Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J 2007;28(1):88- 136
(check this in PDF content)
18
The United States Renal Data System. The United States Renal Data System Annual Data Report 2007. Available at: www.usrds.org
(check this in PDF content)
19
Jafar T, Stark P, Schmid C et al. Proteinuria as a modifiable risk factor for the progression of non-diabetic renal disease. Kidney Int 2001:60:1131-1140
(check this in PDF content)
20
2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2007;28(12):1462-536
(check this in PDF content)
21
Taal MW, Brenner BM. Renal risk scores: Progress and prospects. Kidney Int 2008;73:1216-1219
(check this in PDF content)
22
Mendelssohn DC, Toffelmire EB, Levin A. Attitudes of Canadian nephrologists toward multidisciplinary team-based CKD clinic care. Am J Kidney Dis 2006;47:277-84
(check this in PDF content)
23
Wong CF, McCarthy M, Howse ML, Williams PS Factors affecting survival in advanced chronic kidney disease patients who choose not to receive dialysis. Ren Fail 2007;29(6):653-659 Поступила в редакцию 12.05.2008 г. Принята в печать 22.10.2008 г.
(check this in PDF content)